After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
SOURCE Eli Lilly and Company
The pharmaceutical giant tapped a 20-year company veteran to succeed John Lechleiter, who will retire as president and CEO at yearend.
TheStreet highlights 3 stocks pushing the drugs industry higher today.
Eli Lilly (LLY) announced the resignation of CEO John Lichleiter at the end of 2016.
A TauRx Therapeutics drug designed to dissolve tangles of a protein called tau in the brain failed to slow cognitive and functional declines of Alzheimer's patients compared with a control.
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.